118 related articles for article (PubMed ID: 33212303)
1. GSK2245035, a TLR7 agonist, Does Not Increase Pregnancy Loss in Cynomolgus Monkeys.
Posobiec LM; Hillegas AE; Baker A; Phadnis-Moghe AS; Maier CC; Stanislaus DJ; Bray M; Price MA
J Reprod Immunol; 2021 Feb; 143():103242. PubMed ID: 33212303
[TBL] [Abstract][Full Text] [Related]
2. Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.
Ellis AK; Tsitoura DC; Quint D; Powley W; Lee LA
Clin Exp Allergy; 2017 Sep; 47(9):1193-1203. PubMed ID: 28681506
[TBL] [Abstract][Full Text] [Related]
3. Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement.
Tsitoura D; Ambery C; Price M; Powley W; Garthside S; Biggadike K; Quint D
Clin Pharmacol Ther; 2015 Oct; 98(4):369-80. PubMed ID: 26044169
[TBL] [Abstract][Full Text] [Related]
4. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
Siddall H; Quint D; Pandya H; Powley W; Shabbir S; Hohlfeld JM; Singh D; Lee L
PLoS One; 2020; 15(11):e0240964. PubMed ID: 33166307
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.
Biggadike K; Ahmed M; Ball DI; Coe DM; Dalmas Wilk DA; Edwards CD; Gibbon BH; Hardy CJ; Hermitage SA; Hessey JO; Hillegas AE; Hughes SC; Lazarides L; Lewell XQ; Lucas A; Mallett DN; Price MA; Priest FM; Quint DJ; Shah P; Sitaram A; Smith SA; Stocker R; Trivedi NA; Tsitoura DC; Weller V
J Med Chem; 2016 Mar; 59(5):1711-26. PubMed ID: 26861551
[TBL] [Abstract][Full Text] [Related]
6. Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
Leaker BR; Singh D; Lindgren S; Almqvist G; Eriksson L; Young B; O'Connor B
Respir Res; 2019 Dec; 20(1):288. PubMed ID: 31856838
[TBL] [Abstract][Full Text] [Related]
7. Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach.
Bell J; Dymond M; Biffen M; Delaney S; Keeling D; Zhang H; Robinson I
Toxicol Appl Pharmacol; 2018 Jan; 338():9-19. PubMed ID: 29122671
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel Toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses.
Fosdick A; Zheng J; Pflanz S; Frey CR; Hesselgesser J; Halcomb RL; Wolfgang G; Tumas DB
J Pharmacol Exp Ther; 2014 Jan; 348(1):96-105. PubMed ID: 24133297
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma.
Xirakia C; Koltsida O; Stavropoulos A; Thanassopoulou A; Aidinis V; Sideras P; Andreakos E
Am J Respir Crit Care Med; 2010 Jun; 181(11):1207-16. PubMed ID: 20224068
[TBL] [Abstract][Full Text] [Related]
10. Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis.
Jha A; Thwaites RS; Tunstall T; Kon OM; Shattock RJ; Hansel TT; Openshaw PJM
J Allergy Clin Immunol; 2021 Feb; 147(2):694-703.e12. PubMed ID: 32717253
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.
Wu LS; Hu Y; Gane EJ; Slaets L; De Creus A; Ding Y; Niu J; Schwabe C; Goeyvaerts N; Xu Z; Huo D; Tuefferd M; Verbrugge I; Van Remoortere P; Schwertschlag U; Vandenbossche J
Antivir Ther; 2023 Feb; 28(1):13596535231151626. PubMed ID: 36691849
[TBL] [Abstract][Full Text] [Related]
12. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma.
Forbes RL; Gibson PG; Murphy VE; Wark PA
Thorax; 2012 Mar; 67(3):209-14. PubMed ID: 21917654
[TBL] [Abstract][Full Text] [Related]
13. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-alpha + IFN-gamma) on pregnancy loss.
Clark DA; Manuel J; Lee L; Chaouat G; Gorczynski RM; Levy GA
Am J Reprod Immunol; 2004 Dec; 52(6):370-8. PubMed ID: 15663602
[TBL] [Abstract][Full Text] [Related]
14. Cord blood cytokines and chemokines and development of allergic disease.
Sandberg M; Frykman A; Ernerudh J; Berg G; Matthiesen L; Ekerfelt C; Nilsson LJ; Jenmalm MC
Pediatr Allergy Immunol; 2009 Sep; 20(6):519-27. PubMed ID: 19175890
[TBL] [Abstract][Full Text] [Related]
15. Therapy with TLR7 agonists induces lymphopenia: correlating pharmacology to mechanism in a mouse model.
Perkins H; Khodai T; Mechiche H; Colman P; Burden F; Laxton C; Horscroft N; Corey T; Rodrigues D; Rawal J; Heyen J; Fidock M; Westby M; Bright H
J Clin Immunol; 2012 Oct; 32(5):1082-92. PubMed ID: 22476912
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma.
Medoff BD; Sauty A; Tager AM; Maclean JA; Smith RN; Mathew A; Dufour JH; Luster AD
J Immunol; 2002 May; 168(10):5278-86. PubMed ID: 11994485
[TBL] [Abstract][Full Text] [Related]
17. Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection.
Kader M; Smith AP; Guiducci C; Wonderlich ER; Normolle D; Watkins SC; Barrat FJ; Barratt-Boyes SM
PLoS Pathog; 2013; 9(7):e1003530. PubMed ID: 23935491
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
Kurimoto A; Hashimoto K; Nakamura T; Norimura K; Ogita H; Takaku H; Bonnert R; McInally T; Wada H; Isobe Y
J Med Chem; 2010 Apr; 53(7):2964-72. PubMed ID: 20232824
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.
Kandimalla ER; Bhagat L; Wang D; Yu D; Sullivan T; La Monica N; Agrawal S
Nucleic Acids Res; 2013 Apr; 41(6):3947-61. PubMed ID: 23396449
[TBL] [Abstract][Full Text] [Related]
20. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
